154 related articles for article (PubMed ID: 27422129)
1. Stereotactic brachytherapy using iodine 125 seeds for the treatment of primary and recurrent anaplastic glioma WHO° III.
Suchorska B; Hamisch C; Treuer H; Mahnkopf K; Lehrke RE; Kocher M; Ruge MI; Voges J
J Neurooncol; 2016 Oct; 130(1):123-131. PubMed ID: 27422129
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic brachytherapy of low-grade cerebral glioma after tumor resection.
Suchorska B; Ruge M; Treuer H; Sturm V; Voges J
Neuro Oncol; 2011 Oct; 13(10):1133-42. PubMed ID: 21868412
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children: long-term outcome.
Ruge MI; Simon T; Suchorska B; Lehrke R; Hamisch C; Koerber F; Maarouf M; Treuer H; Berthold F; Sturm V; Voges J
J Clin Oncol; 2011 Nov; 29(31):4151-9. PubMed ID: 21969508
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic iodine-125 brachytherapy for the treatment of WHO grades II and III gliomas located in the central sulcus region.
Ruge MI; Kickingereder P; Grau S; Dorn F; Galldiks N; Treuer H; Sturm V
Neuro Oncol; 2013 Dec; 15(12):1721-31. PubMed ID: 24046261
[TBL] [Abstract][Full Text] [Related]
5. Low-dose rate stereotactic iodine-125 brachytherapy for the treatment of inoperable primary and recurrent glioblastoma: single-center experience with 201 cases.
Kickingereder P; Hamisch C; Suchorska B; Galldiks N; Visser-Vandewalle V; Goldbrunner R; Kocher M; Treuer H; Voges J; Ruge MI
J Neurooncol; 2014 Dec; 120(3):615-23. PubMed ID: 25151509
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic iodine-125 brachytherapy for treatment of inoperable focal brainstem gliomas of WHO grades I and II: feasibility and long-term outcome.
Ruge MI; Kickingereder P; Simon T; Treuer H; Sturm V
J Neurooncol; 2012 Sep; 109(2):273-83. PubMed ID: 22580799
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of stereotactic brachytherapy with temporary Iodine-125 seeds in patients with WHO grade II gliomas.
Watson J; Romagna A; Ballhausen H; Niyazi M; Lietke S; Siller S; Belka C; Thon N; Nachbichler SB
Radiat Oncol; 2020 Dec; 15(1):275. PubMed ID: 33298103
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic interstitial brachytherapy for the treatment of oligodendroglial brain tumors.
El Majdoub F; Neudorfer C; Blau T; Hellmich M; Bührle C; Deckert M; Sturm V; Maarouf M
Strahlenther Onkol; 2015 Dec; 191(12):936-44. PubMed ID: 26307628
[TBL] [Abstract][Full Text] [Related]
9. Outcome and toxicity profile of salvage low-dose-rate iodine-125 stereotactic brachytherapy in recurrent high-grade gliomas.
Schwartz C; Romagna A; Thon N; Niyazi M; Watson J; Belka C; Tonn JC; Kreth FW; Nachbichler SB
Acta Neurochir (Wien); 2015 Oct; 157(10):1757-64; discussion 1764. PubMed ID: 26298594
[TBL] [Abstract][Full Text] [Related]
10. Surgical resection plus stereotactic 125I brachytherapy in adult patients with eloquently located supratentorial WHO grade II glioma - feasibility and outcome of a combined local treatment concept.
Schnell O; Schöller K; Ruge M; Siefert A; Tonn JC; Kreth FW
J Neurol; 2008 Oct; 255(10):1495-502. PubMed ID: 18677635
[TBL] [Abstract][Full Text] [Related]
11. Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas.
Wang C; Liu S; Peng L; Zhang K; Li W; Zhang H; Luan Y; Li P; Hu X
BMC Cancer; 2020 Jun; 20(1):591. PubMed ID: 32580723
[TBL] [Abstract][Full Text] [Related]
12. Early treatment of complex located pediatric low-grade gliomas using iodine-125 brachytherapy alone or in combination with microsurgery.
Kunz M; Nachbichler SB; Ertl L; Fesl G; Egensperger R; Niyazi M; Schmid I; Tonn JC; Peraud A; Kreth FW
Cancer Med; 2016 Mar; 5(3):442-53. PubMed ID: 26714663
[TBL] [Abstract][Full Text] [Related]
13. Radiation necrosis after a combination of external beam radiotherapy and iodine-125 brachytherapy in gliomas.
Hadi I; Reitz D; Bodensohn R; Roengvoraphoj O; Lietke S; Niyazi M; Tonn JC; Belka C; Thon N; Nachbichler SB
Radiat Oncol; 2021 Feb; 16(1):40. PubMed ID: 33622365
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy in supratentorial gliomas. A study of 821 cases.
Heesters M; Molenaar W; Go GK
Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
[TBL] [Abstract][Full Text] [Related]
15. Permanent iodine-125 interstitial radiation therapy in the treatment of non-glioblastoma multiforme high-grade gliomas.
Zamorano L; Li Q; Tekyi-Mensah S; Gaspar L; Fontanesi J; Levin K
Stereotact Funct Neurosurg; 2003; 81(1-4):10-7. PubMed ID: 14742958
[TBL] [Abstract][Full Text] [Related]
16. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic biopsy combined with stereotactic (125)iodine brachytherapy for diagnosis and treatment of locally recurrent single brain metastases.
Ruge MI; Kickingereder P; Grau S; Hoevels M; Treuer H; Sturm V
J Neurooncol; 2011 Oct; 105(1):109-18. PubMed ID: 21479963
[TBL] [Abstract][Full Text] [Related]
18. Interstitial radiation in recurrent malignant gliomas.
Hitchon PW; Jani SK; VanGilder JC; Godersky JC; Doornbos S
Appl Neurophysiol; 1987; 50(1-6):292-4. PubMed ID: 3329866
[TBL] [Abstract][Full Text] [Related]
19. Interstitial brachytherapy versus cytoreductive surgery in recurrent malignant glioma.
Ryken TC; Hitchon PW; VanGilder JC; Wen BC; Jani S
Stereotact Funct Neurosurg; 1994; 63(1-4):241-5. PubMed ID: 7624640
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of surgically treated low-grade gliomas: a retrospective analysis of a single institute.
Turkoglu E; Gurer B; Sanli AM; Dolgun H; Gurses L; Oral NA; Donmez T; Sekerci Z
Clin Neurol Neurosurg; 2013 Dec; 115(12):2508-13. PubMed ID: 24225484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
